The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury
The Journal of Toxicological Sciences · 2023
DOI: 10.2131/jts.48.469 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Toxicological Sciences, 2023. Verfasst von Wenyuan Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Soochow University, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Inflammasomes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
The use of doxorubicin (DOX) may contribute to cardiotoxicity, limiting its clinical application. Thiolutin (THL) has been found to exert protective roles in various biological activities, while its effects on DOX-induced cardiotoxicity are still uncovered. Cell counting kit 8 assay was utilized to detect cell viability and half maximal inhibitory concentration of THL in H9c2 cardiomyocytes. The level of lactate dehydrogenase (LDH), adenosine triphosphate (ATP), interleukin (IL)-18 and IL-1 beta (IL-1β) were measured using the corresponding detection kits, and flow cytometry determined cell apoptosis rate. The reactive oxygen species (ROS) accumulation was evaluated by utilizing immunofluorescence or flow cytometry assay. The protein levels of NLR family Pyrin domain 3 (NLRP3), pro-Caspase1, cleaved-Caspase1, gasdermin D (GSDMD) and cleaved-GSDMD (GSDMD-N) in H9c2 cells were detected by immunoblotting assay. The treatment of THL reduced H9c2 cell viability in a gradient-dependent manner. THL treatment reversed the DOX-induced inhibition of proliferation, decrease of ATP, up-regulation of LDH, IL-18, IL-1β and production of ROS, activation of NLRP3 and inflammasome-mediated pyroptosis in H9c2 cells. Additionally, NLRP3 knockdown abolished the effects of THL in DOX-treated H9c2 cells remarkably. This investigation proved that THL notably ameliorated DOX-induced apoptosis, oxidative stress, and pyroptosis in H9c2 cardiomyocytes. Besides, THL effectively inactivated DOX-induced NLRP3 inflammasome in H9c2 cells. These findings revealed a promising drug to assist DOX in its anti-cancer effects and protect the heart of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Soochow University, China.
- Department of Cardiology, Affiliated Hospital of Jiangnan University, China.
- Department of Geriatrics, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, China.
- Department of Cardiology, Dushu Lake Hospital Affiliated to Soochow University, China.
Zitieren
APA
Cai, W., Teng, T., Wang, X., Li, B., Gu, X., & Zhou, Y. (2023). The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury. The Journal of Toxicological Sciences. https://doi.org/10.2131/jts.48.469
Vancouver
Cai W, Teng T, Wang X, Li B, Gu X, Zhou Y. The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury. The Journal of Toxicological Sciences. 2023. doi:10.2131/jts.48.469
BibTeX
@article{Cai2023,
author = {Cai, Wenyuan and Teng, Tingting and Wang, Xiaoyan and Li, Baihong and Gu, Xin and Zhou, Yafeng},
title = {The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury},
journal = {The Journal of Toxicological Sciences},
year = {2023},
doi = {10.2131/jts.48.469}
}
EUVIMED